2 Biotech Stocks Starting the Week Off Strong

The FDA fast-tracked Prevail's Parkinson's disease treatment

by Patrick Martin

Published on Jul 8, 2019 at 9:53 AM

Two biotech names are making a run up the Nasdaq charts this morning. First there's Sangamo Therapeutics Inc (NASDAQ:SGMO), up 10% to trade at $12.53, after the gene therapy specialist reported positive early-stage results for its hemophilia treatment developed with Pfizer (PFE). An analyst at Cowen and Company said that while the data is encouraging, more follow-ups are needed to fully gauge the drug's long-term impact.

Sangamo Therapeutics stock has used this news to climb just south of $13, an area that contained an early-April bull gap. Prior to today, SGMO was trading just below its year-to-date breakeven point. And barring a dramatic pivot the next four days, the drug stock is staring at its fourth-straight weekly win.

A short squeeze could power more gains. Short interest is at its highest point since mid February, and accounts for 18.8% of SGMO's total available float, and more than eight days' worth of pent-up buying power, at the stock's average pace of trading.  

Then there's Prevail Therapeutics Inc (NASDAQ:PRVL), up 8% to trade at $11.35, after the Food and Drug Administration (FDA) granted 'fast-track' designation for the company's Parkinson's disease treatment. Dosing will begin in the second half of 2019. Prevail Therapeutics stock had its initial public offering (IPO) on June 10, pricing at $17 per share. PRVL raced as high as $16.90 on June 24, but prior to today, had turned in only one positive session since, and has yet to reach $17.


a schaeffer's exclusive

5 NEW STOCK PICKS

We're celebrating 38 years with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The "Trick" Used By the World's Wealthiest
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
2 Retail Stocks at New Lows Today
Escalating U.S.-China trade tensions are creating stiff headwinds
Stocks Erase Weekly Gains After Trump Reacts to China Retailiatory Tariffs
A brief yield-curve inversion also spooked Wall Street
The "Trick" Used By the World's Wealthiest
A simple way to stop picking losers, and start cashing in like Wall Street's elite.